Czechia’s main public health insurance company reports steep increase in Alzheimer patients

The number of Alzheimer patients among the clients of Czechia’s main public health insurance company, VZP, has increased by 13 percent over the last five years, the Czech Statistics Office reported on Wednesday.

In 2022, VZP, whose clients comprise 60 per cent of the population, recorded more than 50,000 clients suffering from Alzheimer’s disease, and their treatment exceeded CZK 1.74 billion.

Overall, the country’s Institute of Health Information and Statistics estimates that there are currently about 100,000 people with Alzheimer's disease in Czechia. By 2030 their number is expected to reach 174,000.